Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Editorial

Medicinal Chemistry Strategies to Combat Neurodegenerative Diseases

Author(s): Elisa Uliassi

Volume 24, Issue 28, 2024

Page: [iv - v] Pages: 2

DOI: 10.2174/156802662428241015163724

conference banner
« Previous
[1]
Wilson, D.M.; Cookson, M.R.; Van Den Bosch, L.; Zetterberg, H.; Holtzman, D.M.; Dewachter, I. Hallmarks of Neurodegenerative Diseases. Cell, 2023, 186(4), 693-714.
[http://dx.doi.org/10.1016/j.cell.2022.12.032]
[2]
Cummings, J.; Zhou, Y.; Lee, G.; Zhong, K.; Fonseca, J.; Cheng, F. Alzheimer’s Disease Drug Development Pipeline: 2024. Alzheimers Dement., 2024, 10(2)
[http://dx.doi.org/10.1002/trc2.12465]
[3]
Cavalli, A.; Bolognesi, M.L.; Minarini, A.; Rosini, M.; Tumiatti, V.; Recanatini, M.; Melchiorre, C. Multi-Target-Directed Ligands to Combat Neurodegenerative Diseases. J. Med. Chem., 2008, 51, 347-372.
[http://dx.doi.org/10.1021/jm7009364]
[4]
Bayraktar, G.; Alptüzün, V. Recent Molecular Targets and Their Ligands for the Treatment of Alzheimer Disease. Curr. Top. Med. Chem., 2024, 24, 1-18.
[http://dx.doi.org/10.2174/0115680266318722240809050235]
[5]
Lopes, F.B.; Fernandes, J.P.S.; Uliassi, E. Tackling Neuroinflammation in Cognitive Disorders with Single-Targeted and Multi-Targeted Histamine H3 Receptor Modulators. Curr. Top. Med. Chem., 2024, 24, 1-10.
[http://dx.doi.org/10.2174/0115680266322294240816051818]
[6]
Kar, S.S.; Gharai, S.R.; Sahu, S.K.; Ravichandiran, V.; Swain, S.P. The Current Landscape in the Development of Small-Molecule Modulators Targeting Sphingosine-1-Phosphate Receptors to Treat Neurodegenerative Diseases. Curr. Top. Med. Chem., 2024, 24, 1-16.
[http://dx.doi.org/10.2174/0115680266288509240422112839]

© 2024 Bentham Science Publishers | Privacy Policy